3,815
Views
29
CrossRef citations to date
0
Altmetric
Review

Magnetic nanoparticles: Applications in gene delivery and gene therapy

, , , , , & show all
Pages 1186-1193 | Received 17 Jan 2015, Accepted 28 Jan 2015, Published online: 02 Mar 2015

References

  • Abbasi E, Abolfazl A, Kouhi M, Milani M. 2014a. Graphene: Synthesis, Bio-Applications, and Properties. Artif Cells Nanomed Biotechnol. 1–7.
  • Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, et al. 2014b. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 9:247.
  • Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H. 2014c. Silver nanoparticles: synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 1–8.
  • Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H, et al. 2014d. Silver nanoparticles: Synthesis, properties, bio-applications and limitations. Crit Rev Microbiol. 1–8.
  • Afsaneh S, Reza HH, Mohammad AB, Shayan Z, Nosratolah Z, Abolfazl A. 2014. The association between serum KALRN levels with polymorphism gene KALRN (rs9289231) with risk of early-onset coronary artery disease (CAD). Molecular Biology Reports.
  • Ahmadi A, Shirazi H, Pourbagher N, Akbarzadeh A, Omidfar K. 2014. An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels. Mol Biol Rep. 41: 1659–1668.
  • Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: Classification, Preparation, and Applications. Nanoscale Res Lett, 8:102.
  • Akbarzadeh A, Mikaeili H, Asgari D, Zarghami N, Mohammad R, Davaran S. 2012a.Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–526.
  • Akbarzadeh A, Samiei M, Davaran S. 2012b. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7:144.
  • Akbarzadeh A, Samiei M, Davaran S. 2012c.Magnetic Nanoparticles: Preparation, Physical Properties and Applications in biomedicine. Nanoscale Res lett. 7:144–157.
  • Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012d. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnology. 10:46–58.
  • Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Davaran S. 2012e. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Int J Nanotechnol Sci Environ. 5:13–25.
  • Alimirzalu S, Akbarzadeh A, Abbasian M, Alimohammadi S, Davaran S, Younes H, et al. 2014. Synthesis and study of physicochemical characteristics of Fe3O4 magnetic nanocomposites based on poly(Nisopropylacrylamide)for anti-cancer drugs delivery. Asian Pac J Cancer Prev 15:49–54.
  • Alizadeh E, Akbarzadeh A, Zarghami N, Eslaminejad BM, Hashemzadeh S, Nejati-Koshki K. 2014. Up-regulation of Liver enriched Transcription Factors (HNF4a and HNF6) and Liver Specific MicroRNA (miR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells. Chem Biol Drug Des. 85:600–608.
  • Alizadeh E, Zarghami N, Eslaminejad BM, Akbarzadeh A, Barzegar A, Mohammadi SA. 2014. The Effect of Dimethyl Sulfoxide (DMSO) on Hepatic Differentiation of Mesenchymal Stem Cells. Artif Cells Nanomed Biotechnol. 1–8.
  • Anganeh MT, Mirakabad FST, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014a. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosci. 4:134–145.
  • Anganeh TM, Mirakabad FST, Izadi M, Zeighamian V, Badrzadeh F, Salehi R, et al. 2014b. The comparison between effects of free curcumin and curcumin loaded PLGA-PEG on telomerase and TRF1 expressions in calu-6 lung cancer cell line. Int J Biosciences. 4: 134–145.
  • Badrzadeh F, Akbarzadeh A, Zarghami N, Yamchi MR, Zeighamian V, Tabatabae FS, et al. 2014a. Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac J Cancer Prev. 15:8931–8936.
  • Badrzadeh F, Rahmati-Yamchi M, Badrzadeh K, Valizadeh A, Zarghami N, Farkhani SM, Akbarzadeh A. 2014b. Drug delivery and nanodetection in lung cancer. Artif Cells Nanomed Biotechnol. Early Online:1–17.
  • Barkhordari A, Rahmati YM, Fekri S, Pourhassan-Moghaddam M, Nejati KK, Davaran S, et al. 2014. Study of inhibitory effect of Helenalin on hTERT gene expression in breast cancer cell line by Real-time PCR. Bio infopublications. In Press 2014.
  • Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, et al. 2005. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Pro Natl Acad Sci USA. 102:11539–11544.
  • Bigger BW, Tolmachov O, Collombet JM, Fragkos M, Palaszewski I, Coutelle C. 2001. An araC-controlled bacterialcre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem. 276:23018–23027.
  • Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P. 1996Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul. 13:245–255.
  • Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2014. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 1–8.
  • Conwell CC, Huang L. 2005. Recent advances in non-viral gene delivery. Adv Genet. 53:1–18.
  • Dadashzadeh K, Milani M, Rahmati M, Akbarzadeh A. 2014a. Real-Time PCR detection of 16S rRNA novel mutations associated with Helicobacter pylori tetracycline resistance in Iran. Asian Pac J Cancer Prev. 15:8883–8886.
  • Dadashzadeh K, Milani M, Rahmati M, Akbarzadeh A. 2014b.Real-Time PCR detection of 16S rRNA novel mutations associated with Helicobacter pylori tetracycline resistance in Iran. APJCP. 15: 8883–8886.
  • Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 1–13.
  • Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2014b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 1–11.
  • Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Farajpour GM, Soghrati MM, et al. 2013. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release. JEAS. 3:108–115.
  • Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A. 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide– β -cyclodextrin copolymer nanoparticles containing albumin. ANP. 3:14–22.
  • Davoudi Z, Akbarzadeh A, Rahmatiyamchi M, Movassaghpour AA, Alipour M, Nejati-Koshki K, et al. 2014. Molecular Target Therapy of AKT and NF-kB Signaling Pathways and Multidrug Resistance by Specific Cell Penetrating Inhibitor Peptides in HL-60 Cells. APJCP. 15:4353.
  • Deelman L, Sharma K. 2009. Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens. 18: 85–90.
  • Dizaj SM, Jafari S, Khosroushahi AY. 2014. A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res Lett. 9:252.
  • Dobson J. 2006Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 13:283–287.
  • Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, et al. 2014a. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 9:1–13.
  • Eatemadi A, Daraee H, Zarghami N, Melat YH, Akbarzadeh A, Hanifehpour Y. 2014b. Nanofiber; synthesis and biomedical applications Artif Cells Nanomed Biotechnol. 1–11.
  • Ebrahimi E, Abbasi E, Akbarzadeh A, Khandaghi AA, Davaran S. 2014a. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol. 1–8.
  • Ebrahimi E, Khandaghi AA, Valipour F, Babaie S, Asghari F, Motaali S, et al. 2014b. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers. Artifi Cells Nanomed Biotechnol. Early Online:1–9.
  • Ebrahimnezhad Z, Zarghami N, Keyhani M, Amirsaadat S, Akbarzadeh A, Rahmati M, et al. 2013. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts. 3:67–74.
  • Fallahzadeh S, Bahrami H, Akbarzadeh A, Tayarani M. 2010. High- isolation dual-frequency operation patch antenna using spiral defected microstrip structure. Antenn Wirel Pr Letters, IEEE. 9:122–124.
  • Fekri Aval S, Akbarzadeh A, Yamchi MR, Zarghami F, Nejati-Koshki K, Zarghami N. 2014. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line. Artif Cells Nanomed Biotechnol. Early Online:1–6.
  • Ghalhar MG, Akbarzadeh A, Rahmati M, Mellatyar H, Dariushnejad H, Zarghami N, Barkhordari A. 2014. Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer. Asian Pac J Cancer Prev. 15:7113–7118.
  • Ghasemali S, Nejati-Koshki K, Akbarzadeh A, Tafsiri E, Zarghami N, Rahmati-Yamchi M, et al. 2013. Study of Inhibitory Effect of β-Cyclodextrin-HelenalinComplex on HTERT Gene Expression in T47D Breast Cancer Cell Line by Real TimeQuantitative PCR (q-PCR). Asian Pac J Cancer Prev. 14:6949–6953.
  • Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St. Pierre TG, Saunders M. 2003. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater, 15:1367–1377.
  • Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN. 2010. Tissue-specific gene delivery via nanoparticle coating. Biomaterials. 31:998–1006.
  • Hendriks WT, Ruitenberg MJ, Blits B, Boer GJ, Verhaagen J. 2004. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res. 146: 451–476.
  • Herizchi R, Abbasi E, Milani M, Akbarzadeh A. 2014. Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol. Early Online:1–7.
  • Higashi T, Khalil IA, Maiti KK, Lee WS, Akita H, Harashima H, Chung SK. 2009. Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery. J Cont Rel. 136:140–147.
  • Hosseininasab S, Pashaei-Asl R, Ahmad KA, Nasrabadi HT, Nejati-Koshki K, Akbarzadeh A, et al. 2014. Synthesis, characterization, and In vitro studies of PLGA-PEG nanoparticles for oral Insulin delivery. Chem Biol Drug Des. 84:307–315.
  • Hughes C, Galea-Lauri J, Farzaneh F, Darling D. 2001. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. Mol Ther. 3:623–630.
  • Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U, Rosenecker J. 2004. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med. 6:923–936.
  • Indira TK, Lakshmi PK. 2010. Magnetic nanoparticles - A review. Int J Pharm Sci Nanotechnol. 3:1035–1042.
  • Jalil K-H, Mobasseri M, Akbarzadeh A, Soodabeh D, Ostad-Rahimi A, Hamishehkar H, et al. 2014. Preparation of pH sensitive insulin-loaded Nano hydrogels and evaluation of insulin releasing in different pH conditions. Molecular Biology Reports. Mol Biology Rep. 41:6705–6712.
  • Jin L, Zeng X, Liu M, Deng Y, He N. 2014. Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics. 4:240–55.
  • Kafshdooz T, Kafshdooz L, Akbarzadeh A, Hanifehpour Y, Joo SW. 2014. Applications of nanoparticle systems in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol. Early Online:1–7.
  • Kami D, Takeda S, Itakura Y, Gojo S, Watanabe M, Toyoda M. 2011. Application of magnetic nanoparticles to gene delivery. Int J Mol Sci. 12:3705–3722.
  • Kordi S, Zarghami N, Rahmati YM, Ghasemali S, Tozihi M, Nejati-Koshki K, Akbarzadeh A. 2014. The Comparison of inhibitory effect of nanocapsolated Helenalin and free Helenalin on Telomerase gene expression in breast cancer cell line by Real-time PCR. Artif Cells Nanomed Biotechnol. Early Online:1–17.
  • Kostarelos K, AD Miller. 2005. Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev. 34:970–994.
  • Kouhi M, Vahedi A, Akbarzadeh A, Hanifehpour Y, Sang Woo J. 2014. Investigation of quadratic electro-optic effects and electro absorption process in GaN/AlGaN spherical quantum dot. Nanoscale Res Lett. 9:131–136.
  • Lee J-M, Yoon T-J, Cho Y-S. 2013. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. Biomed Res Int. 2013:782041
  • Li C, L Li, AC Keates. 2012. Targeting cancer gene therapy with magnetic nanoparticles. Oncotarget. 3:365–70.
  • Lu Y, 2009. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer. Adv Drug Deliv Rev. 61:572–588.
  • Mah C, Fraites TJ Jr, Zolotukhin I, Song S, Flotte TR, Dobson J, et al. 2000. Microsphere-mediated delivery of recombinant AAV vectors in vitro and in vivo. Mol Ther. 1:S239.
  • Mah C, Fraites TJ Jr, Zolotukhin I, Song S, Flotte TR, Dobson J, et al. 2002. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol Ther. 6:106–112.
  • Mastrobattista E, van der Aa MA, Hennink WE, Crommelin DJ. 2006. Artificial viruses: a nanotechnological approach to gene delivery. Nat Rev Drug Discov. 5:115–121.
  • Mayrhofer P, Schleef M, Jechlinger W. 2009. Use of minicircle plasmids for gene therapy, in Gene Therapy of Cancer. Springer, pp. 87–104.
  • McBain SC, Yiu HH, Dobson J. 2008. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine. 3:169.
  • Mellatyar H, Akbarzadeh A, Rahmati M, Ghalhar MG, Etemadi A, Nejati-Koshki K, Zarghami N, Barkhordari A. 2014. Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pac J Cancer Prev. 15:8693–8698.
  • Mollazade M, Nejati-Koshki K, Abolfazl A, Younes H, Zarghami N, Sang Woo J. 2013. PAMAM dendrimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev. 14:6925–6928.
  • Morachis JM, Mahmoud EA, Sankaranarayanan J, Almutairi A, 2012. Triggered rapid degradation of nanoparticles for gene delivery. J Drug Deliv. 2012:291219
  • Morishita N, Nakagami H, Morishita R, Takeda S, Mishima F, Terazono B, et al. 2005. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun. 2005. 334:1121–1126.
  • Namiki Y, Namiki T, Yoshida H, Ishii Y, Tsubota A, Koido S, et al. 2009.A novel magnetic crystal “lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol. 4:598–606.
  • Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2014. Bimetallic nanoparticles: Preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 1–5.
  • Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghaddam M, Abhari A, Dariushnejad H. 2013. Inhibition of Leptin and Leptin Receptor Gene Expression by Silibinin-Curcumin Combination. Asian Pac J Cancer Prev. 14:6595–6599.
  • Nejati-Koshki K, Mesgari M, Ebrahimi E, Abhari A, Aval FS, Khandaghi AA, Akbarzadeh A. 2014. Synthesis and In-vitro study of Cisplatin-loaded Fe3O4 Nanoparticles Modified with PLGA-PEG6000 Copolymers in Treatment of Lung Cancer. J Microencapsulation. 1–9.
  • Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B 2005. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater, 293:483–496.
  • Niidome T, Huang L. 2002. Gene therapy progress and prospects: nonviral vectors. Gene Ther, 9:1647–1652.
  • Nitta SK, Numata K. 2013. Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci. 14:1629–1654.
  • Pack DW, Hoffman AS, Pun S, Stayton PS. 2005. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 4: 581–593.
  • Pankhurst QA, Thanh NTK, Jones SK, Dobson J. 2003. Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys. 36:R167.
  • Park TG, Jeong JH, Kim SW. 2006. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev. 58:467–486.
  • Philippi C, Loretz B, Schaefer UF, Lehr CM 2010. Telomerase as an emerging target to fight cancer-opportunities and challenges for nanomedicine. J Cont Rel. 146:228–240.
  • Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Sang Woo J. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8:485.
  • Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, Rahmati-Yamchi M, Gholizadeh D, Akbarzadeh A, de la Guardia M, Nejati-Koshki K. 2014. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. IET Digital Library. 9:345–350.
  • Pouton CW, Seymour LW. 2001. Key issues in non-viral gene delivery. Adv Drug Deliv Rev. 46:187–203.
  • Prijic S, G Sersa 2011. Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol. 45:1–16.
  • Putnam D, 2006. Polymers for gene delivery across length scales. Nat Mater. 5:439–451.
  • Rahimzadeh A, Tabatabaei Mirakabad FS, Movassaghpour A, Shamsasenjan K, Kariminekoo S, Talebi M, et al. 2014. Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system. Artifi Cells Nanomed Biotechnol. Early Online:1–12.
  • Rapti K, Chaanine AH, Hajjar RJ. 2011. Targeted gene therapy for the treatment of heart failure. Can J Cardiol. 27:265–283.
  • Rezaei-Sadabady R, Zarghami N, Barzegar A, Eidi A, Akbarzadeh A, Rezaei-Tavirani M. 2013. Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft. 2:13–18.
  • Robbins PD, Ghivizzani SC. 1998. Viral vectors for gene therapy. Pharmacol Ther. 80:35–47.
  • Sadat TMF, Nejati-Koshki K, Akbarzadeh A, Yamchi MR, Milani M, Zarghami N, et al. 2014. PLGA-Based Nanoparticles As Cancer Drug Delivery Systems. Asian Pac J Cancer Prev. 15:517–535.
  • Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Krüger A, et al. 2002. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9:102–109.
  • Schlorf T, Meincke M, Kossel E, Glüer CC, Jansen O, Mentlein R. 2010. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int J Mol Sci. 12:12–23.
  • Schwerdt JI., Goya GF, Calatayud MP, Hereñú CB, Reggiani PC, Goya RG, et al. 2012. Magnetic field-assisted gene delivery: achievements and therapeutic potential. Curr Gene Ther. 12:116–126.
  • Sinha R, Kim GJ, Nie S, Shin DM. 2006Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol cancer Ther. 5:1909–1917.
  • Sohrabi N, Valizadeh A, Farkhani SM, Akbarzadeh A. 2014. Basics of DNA biosensors and cancer diagnosis. Artif Cells Nanomed Biotechnol. Early Online:1–10.
  • Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, et al. 2014. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 1–8.
  • Thomas CE, Ehrhardt A, Kay MA. 2003. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 4:346–358.
  • Tozihi M, Zarghami N, Rahmati M, Nejati-Koshki K, Akbarzadeh A, Mohamadian J, et al. 2014. CDH1 and FGFR2 gene Polymorphisms in Breast Cancer Patients. Int J Biosci. InPress.
  • Valizadeh A, Bakhtiary M, Akbarzadeh A, Salehi R, Frakhani SM, Ebrahimi O, et al. 2014. Preparation and characterization of novel electrospun poly(e-caprolactone)-based nanofibrous scaffolds. Artif Cells Nanomed Biotechnol. Early Online:1–6.
  • Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett, 7:276
  • Widder KJ, Senyel AE, Scarpelli DG. 1978. Magnetic microspheres: a model system for site specific drug delivery in vivo. Proc Soc Exp Biol Med. 158:141–146.
  • Wu W, He Q, Jiang C. 2008. Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies. Nanoscale Res Lett, 3:397–415.
  • Zheng X, Lu J, Deng L, Xiong Y, Chen J. 2009. Preparation and characterization of magnetic cationic liposome in gene delivery. Int Pharm. 366:211–217.
  • Zhou J, Neff CP, Liu X, Zhang J, Li H, Smith DD, Swiderski P, et al. 2011. Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice. Mol Ther. 19:2228–2238.
  • Zohre S, Kazem NK, Abolfazl A, Mohammad RY, Aliakbar M, Effat A, et al. 2014. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. Asian Pac J Cancer Prev. 15:6581–6586.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.